Seroprevalence of SARS-CoV-2 neutralising antibodies and cross-reactivity to JN.1 one year after the BA.5/BF.7 wave in China.
Lancet Reg Health West Pac
; 44: 101040, 2024 Mar.
Article
in En
| MEDLINE
| ID: mdl-38495840
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Lancet Reg Health West Pac
Year:
2024
Document type:
Article
Affiliation country:
China
Country of publication:
Reino Unido